Clinical trials
Phase 2 Diabetic Retinopathy trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2015 | 1 |
| 2021 | 3 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adolfo Daniel Rodriguez-Carrizalez | 1 |
| Attila Vajas | 1 |
| Edward Hines Jr. VA Hospital | 1 |
| Guizhou Bailing Group Pharmaceutical Co Ltd | 1 |
| Rafic Hariri University Hospital | 1 |
| RemeGen Co., Ltd. | 1 |
| University of Sao Paulo | 1 |
| Valo Health, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetic Retinopathy | 8 |
| Macular Edema | 2 |
| Choroidal Neovascularization | 1 |
| Diabetes Mellitus | 1 |
| Dry Eye Syndromes | 1 |
| Macular Degeneration | 1 |
| Neovascularization, Pathologic | 1 |
| Pterygium | 1 |
| Retinal Diseases | 1 |
| Retinal Neovascularization | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.